NervGen Pharma Corp. (TSXV: NGEN)
Canada
· Delayed Price · Currency is CAD
2.870
+0.010 (0.35%)
Jan 31, 2025, 11:08 AM EST
NervGen Pharma Employees
NervGen Pharma had 7 employees as of December 31, 2019.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
201.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2019 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Green Thumb Industries | 4,561 |
WELL Health Technologies | 1,507 |
dentalcorp Holdings | 9,900 |
Curaleaf Holdings | 5,650 |
Trulieve Cannabis | 5,400 |
Sienna Senior Living | 12,263 |
Cronos Group | 356 |
Extendicare | 23,000 |
NervGen Pharma News
- 1 day ago - NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Newsfile Corp
- 21 days ago - NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration - Seeking Alpha
- 4 weeks ago - NervGen Completes Enrollment in Chronic Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury - Newsfile Corp
- 4 weeks ago - Undercovered Dozen: OppFi, PowerFleet, Eletrobras, American Battery + - Seeking Alpha
- 5 weeks ago - NervGen: Data For Spinal Cord Injury Treatment Candidate Likely For Mid-2025 - Seeking Alpha
- 6 weeks ago - NervGen Announces "At-The-Market" Equity Program - Newsfile Corp
- 2 months ago - NervGen Pharma GAAP EPS of -$0.07 - Seeking Alpha
- 2 months ago - NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates - Newsfile Corp